A novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy

Abstract A novel specific spin-labeling strategy for bioactive molecules is presented for eptifibatide (integrilin) an antiplatelet aggregation inhibitor, which derives from the venom of certain rattlesnakes. By specifically labeling the disulfide bridge this molecule becomes accessible for analytic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kevin Herr, Max Fleckenstein, Martin Brodrecht, Mark V. Höfler, Henrike Heise, Fabien Aussenac, Torsten Gutmann, Michael Reggelin, Gerd Buntkowsky
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3e3cc9a70aab41148a91c6390f29b657
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3e3cc9a70aab41148a91c6390f29b657
record_format dspace
spelling oai:doaj.org-article:3e3cc9a70aab41148a91c6390f29b6572021-12-02T16:10:27ZA novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy10.1038/s41598-021-92975-62045-2322https://doaj.org/article/3e3cc9a70aab41148a91c6390f29b6572021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92975-6https://doaj.org/toc/2045-2322Abstract A novel specific spin-labeling strategy for bioactive molecules is presented for eptifibatide (integrilin) an antiplatelet aggregation inhibitor, which derives from the venom of certain rattlesnakes. By specifically labeling the disulfide bridge this molecule becomes accessible for analytical techniques such as Electron Paramagnetic Resonance (EPR) and solid state Dynamic Nuclear Polarization (DNP). The necessary spin-label was synthesized and inserted into the disulfide bridge of eptifibatide via reductive followed by insertion by a double Michael addition under physiological conditions. This procedure is universally applicable for disulfide containing biomolecules and is expected to preserve their tertiary structure with minimal change due to the small size of the label and restoring of the previous disulfide connection. HPLC and MS analysis show the successful introduction of the spin label and EPR spectroscopy confirms its activity. DNP-enhanced solid state NMR experiments show signal enhancement factors of up to 19 in 13C CP MAS experiments which corresponds to time saving factors of up to 361. This clearly shows the high potential of our new spin labeling strategy for the introduction of site selective radical spin labels into biomolecules and biosolids without compromising its conformational integrity for structural investigations employing solid-state DNP or advanced EPR techniques.Kevin HerrMax FleckensteinMartin BrodrechtMark V. HöflerHenrike HeiseFabien AussenacTorsten GutmannMichael ReggelinGerd BuntkowskyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kevin Herr
Max Fleckenstein
Martin Brodrecht
Mark V. Höfler
Henrike Heise
Fabien Aussenac
Torsten Gutmann
Michael Reggelin
Gerd Buntkowsky
A novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy
description Abstract A novel specific spin-labeling strategy for bioactive molecules is presented for eptifibatide (integrilin) an antiplatelet aggregation inhibitor, which derives from the venom of certain rattlesnakes. By specifically labeling the disulfide bridge this molecule becomes accessible for analytical techniques such as Electron Paramagnetic Resonance (EPR) and solid state Dynamic Nuclear Polarization (DNP). The necessary spin-label was synthesized and inserted into the disulfide bridge of eptifibatide via reductive followed by insertion by a double Michael addition under physiological conditions. This procedure is universally applicable for disulfide containing biomolecules and is expected to preserve their tertiary structure with minimal change due to the small size of the label and restoring of the previous disulfide connection. HPLC and MS analysis show the successful introduction of the spin label and EPR spectroscopy confirms its activity. DNP-enhanced solid state NMR experiments show signal enhancement factors of up to 19 in 13C CP MAS experiments which corresponds to time saving factors of up to 361. This clearly shows the high potential of our new spin labeling strategy for the introduction of site selective radical spin labels into biomolecules and biosolids without compromising its conformational integrity for structural investigations employing solid-state DNP or advanced EPR techniques.
format article
author Kevin Herr
Max Fleckenstein
Martin Brodrecht
Mark V. Höfler
Henrike Heise
Fabien Aussenac
Torsten Gutmann
Michael Reggelin
Gerd Buntkowsky
author_facet Kevin Herr
Max Fleckenstein
Martin Brodrecht
Mark V. Höfler
Henrike Heise
Fabien Aussenac
Torsten Gutmann
Michael Reggelin
Gerd Buntkowsky
author_sort Kevin Herr
title A novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy
title_short A novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy
title_full A novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy
title_fullStr A novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy
title_full_unstemmed A novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy
title_sort novel strategy for site selective spin-labeling to investigate bioactive entities by dnp and epr spectroscopy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3e3cc9a70aab41148a91c6390f29b657
work_keys_str_mv AT kevinherr anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT maxfleckenstein anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT martinbrodrecht anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT markvhofler anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT henrikeheise anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT fabienaussenac anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT torstengutmann anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT michaelreggelin anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT gerdbuntkowsky anovelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT kevinherr novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT maxfleckenstein novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT martinbrodrecht novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT markvhofler novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT henrikeheise novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT fabienaussenac novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT torstengutmann novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT michaelreggelin novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
AT gerdbuntkowsky novelstrategyforsiteselectivespinlabelingtoinvestigatebioactiveentitiesbydnpandeprspectroscopy
_version_ 1718384404924989440